These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Folliculotropic mycosis fungoides (stage IIA) progressing to Sézary syndrome: a case report. Agar N; Whittaker SJ Br J Dermatol; 2008 Nov; 159(5):1197-9. PubMed ID: 18764843 [TBL] [Abstract][Full Text] [Related]
3. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings. Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144 [TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [TBL] [Abstract][Full Text] [Related]
5. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides. Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425 [TBL] [Abstract][Full Text] [Related]
6. Mycosis fungoides and Sezary syndrome against a human immunodeficiency virus-positive background: case report. Gahongayire F Int J Dermatol; 2007 Oct; 46 Suppl 1():32-5. PubMed ID: 17919204 [TBL] [Abstract][Full Text] [Related]
7. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas. Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809 [TBL] [Abstract][Full Text] [Related]
8. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe. Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542 [TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970 [TBL] [Abstract][Full Text] [Related]
11. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies. Pai RK; Mullins FM; Kim YH; Kong CS Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522 [TBL] [Abstract][Full Text] [Related]
12. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome. Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128 [TBL] [Abstract][Full Text] [Related]
13. CD4+, CD56+ mycosis fungoides: case report and review of the literature. Horst BA; Kasper R; LeBoit PE Am J Dermatopathol; 2009 Feb; 31(1):74-6. PubMed ID: 19155730 [TBL] [Abstract][Full Text] [Related]
14. [Mycosis fungoides and Sézary syndrome: diagnostic and prognostic relevance of cellular antigen expression]. Meissner K; Löning T; Rehpenning W Hautarzt; 1991 Feb; 42(2):84-91. PubMed ID: 2037492 [TBL] [Abstract][Full Text] [Related]
15. CD25+ folliculotropic Sézary syndrome with CD30+ large cell transformation. Jang MS; Kang DY; Han SH; Park JB; Kim ST; Suh KS Australas J Dermatol; 2014 Feb; 55(1):e4-8. PubMed ID: 23190349 [TBL] [Abstract][Full Text] [Related]
16. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes. Wechsler J; Bagot M; Nikolova M; Parolini S; Martin-Garcia N; Boumsell L; Moretta A; Bensussan A J Pathol; 2003 Jan; 199(1):77-83. PubMed ID: 12474229 [TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880 [TBL] [Abstract][Full Text] [Related]
18. Epidermal Langerhans cells in mycosis fungoides and Sézary syndrome. Matejka M; Konrad K Wien Klin Wochenschr; 1983 Dec; 95(23):847-52. PubMed ID: 6670281 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological differential diagnosis of mycosis fungoides/Sézary syndrome from the cutaneous type of adult T-cell leukemia/lymphoma]. Johno M; Ono T Nihon Rinsho; 2000 Mar; 58(3):660-4. PubMed ID: 10741142 [TBL] [Abstract][Full Text] [Related]
20. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases. Arai E; Katayama I; Ishihara K Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]